Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
Long-term entecavir, TDF effective in chronic HBV in real-world setting

Long-term entecavir, TDF effective in chronic HBV in real-world setting

New method could lead to improved treatment for NPC patients

New method could lead to improved treatment for NPC patients

Loyola's Genomics Facility uses next generation sequencing to study genetic make-up of organisms

Loyola's Genomics Facility uses next generation sequencing to study genetic make-up of organisms

Breast cancer survivors at increased risk of developing thyroid cancer, finds new study

Breast cancer survivors at increased risk of developing thyroid cancer, finds new study

SARAH study completes patient enrolment to evaluate treatment for primary liver cancer

SARAH study completes patient enrolment to evaluate treatment for primary liver cancer

BUSM researchers discover genes involved in formation of lung tumors

BUSM researchers discover genes involved in formation of lung tumors

Higher intake of lycopene may lower risk of renal cell carcinoma in postmenopausal women

Higher intake of lycopene may lower risk of renal cell carcinoma in postmenopausal women

Study focuses on improving therapeutic outcomes in cancer patients through diet-drug combination

Study focuses on improving therapeutic outcomes in cancer patients through diet-drug combination

EORTC researchers review potential treatment options for patients with locally advanced breast cancer

EORTC researchers review potential treatment options for patients with locally advanced breast cancer

ABIVAX doses first patient in ABX203 Phase IIb/III trial for treatment of chronic hepatitis B

ABIVAX doses first patient in ABX203 Phase IIb/III trial for treatment of chronic hepatitis B

Sorafenib, sunitinib provide no benefit to patients with locally advanced kidney cancer

Sorafenib, sunitinib provide no benefit to patients with locally advanced kidney cancer

Study results report no benefit from use of sunitinib, sorafenib among patients with kidney cancer

Study results report no benefit from use of sunitinib, sorafenib among patients with kidney cancer

New HPV vaccine has potential to prevent 90% of conditions triggered by HPV

New HPV vaccine has potential to prevent 90% of conditions triggered by HPV

Regulus Therapeutics reports net loss of $22.2 million for fourth quarter 2014

Regulus Therapeutics reports net loss of $22.2 million for fourth quarter 2014

Researchers identify molecule that plays key role in aggressive thyroid cancer, other cancers

Researchers identify molecule that plays key role in aggressive thyroid cancer, other cancers

MD Anderson Cancer Center to host annual Making Cancer History seminar in Sarasota

MD Anderson Cancer Center to host annual Making Cancer History seminar in Sarasota

Wistar researchers identify new therapeutic target for aggressive form of ovarian cancer

Wistar researchers identify new therapeutic target for aggressive form of ovarian cancer

New laser technology shows promise for cancer treatment

New laser technology shows promise for cancer treatment

Researchers develop novel strategy in fight against cancer

Researchers develop novel strategy in fight against cancer

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.